Lemon, S.M., and Thomas D.L. (1997) Vaccines to prevent viral hepatitis. N Engl J Med336 (3), 196–204.
Neuzil, K.M., et al. (2001) Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J20 (8), 733–40.
Roush, S.W., and Murphy, T.V. (2007) Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA298 (18), 2155–63.
Simons, E., et al. (2012) Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data. Lancet 379 (9832), 2173–8.
Zhang, L., et al. (2012) Acellular vaccines for preventing whooping cough in children. Cochrane Database Syst Rev3, CD001478.
Institute of Medicine. (2012) Adverse effects of vaccines: evidence and causality. Washington, D.C.: The National Academies Press.
Barlow, W.E., et al. (2001) The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med345 (9), 656–61.
Mantadakis, E., Farmaki E., and Buchanan, G.R. (2010) Thrombocytopenic purpura after measles–mumps–rubella vaccination: a systematic review of the literature and guidance for management. J Pediatr156 (4), 623–8.
Perry, R.T., and Halsey, N.A. (2004) The clinical significance of measles: a review. J Infect Dis189 Suppl 1: S4–16.
Pulendran, B., and Ahmed, R. 2011 Immunological mechanisms of vaccination. Nat Immunol12 (6), 509–17.
Stowe, J., et al. (2009) Investigation of the temporal association of Guillain–Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database. Am J Epidemiol169(3), 382–8.
Wraith, D.C., Goldman, M. and Lambert, P.H. (2003) Vaccination and autoimmune disease: what is the evidence? Lancet362 (9396), 1659–66.
Alberts, B., et al. (2007) Molecular Biology of the Cell. 5th edition. New York: Garland Science.
Murphy, K., Travers, P., and Walport, M. (2007) Janeway’s Immunobiology. 7th edition. Garland Science: 928.
Banchereau, J., and Steinman, R.M. (1998) Dendritic cells and the control of immunity. Nature392 (6673), 245–52.
Gowans, J.L., McGregor, D.D., and Cowen, D.M. (1962) Initiation of immune responses by small lymphocytes. Nature196: 651–5.
Miller, J.F. (1961) Immunological function of the thymus. Lancet2 (7205), 748–9.
Miller, J.F. and Mitchell, G.F. (1968) Cell to cell interaction in the immune response. I. Hemolysin- forming cells in neonatally thymectomized mice reconstituted with thymus or thoracic duct lymphocytes. J Exp Med128 (4), 801–20.
Roitt, I.M., et al. (1969) The cellular basis of immunological responses. A synthesis of some current views. Lancet2 (7616), 367–71.
Zinkernagel, R.M., and Doherty, P.C. (1974) Restriction of in vitro T-cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature248 (450), 701–2.
Burnet, F.M. (1959) The Clonal Selection Theory of Acquired Immunity. London: Cambridge University Press.
Ahmed, R., and Gray, D. (1996) Immunological memory and protective immunity: understanding their relation. Science, 272 (5258), 54–60.
Sallusto, F., et al. (2010) From vaccines to memory and back. Immunity33 (4), 451–63.
Panum, P.L. (1847) Observations made during the epidemic of measles on the Faroe Islands in the year 1846. Bibiliothek for Laeger, Copenhagen, 3R 1, 270–344.
Adkins, B., Leclerc, C. and Marshall-Clarke, S. (2004) Neonatal adaptive immunity comes of age. Nat Rev Immunol4 (7), 553–64.
Thucydides. The History of the Peloponnesian War. Everyman’s Library (1910), London: J. M. Dent Ltd.
Hopkins, D.R. (2002) The Greatest Killer: Smallpox in History. Chicago: The University of Chicago Press.
Montagu, M.W. (1796) Letter 36 to Mrs SC from Adrianople. Letters of the Right Honourable Lady Written during her travels in Europe, Asia and Africa. Aix. Anthony Henricy. 1: 167–169.
Jenner, E. (1798) An Enquiry Into the Causes and Effects of the Variolae Vaccinae or Cow-pox. Harvard Classics, New York: P.F. Collier & Son.
Fenner, F. (1999) Nature, nurture and my experience with smallpox eradication. Med J Aust171 (11–12), 638–41.
World Health Organisation. (2009) Hepatitis B vaccines. Wkly Epidemiol Rec84 (40), 405–19.
Ascherio, A., et al. (2001) Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 344 (5), 327–32.
Karvonen, M., Cepaitis, Z. and Tuomilehto, J. (1999) Association between type 1 diabetes and Haemophilus influenzae type b vaccination: birth cohort study. BMJ318 (7192), 1169–72.
No authors listed. (2002) Hepatitis B vaccine and demyelinating neurological disorders. Immunisation Safety Review. Washington D.C.: The National Academies Press.
Bach, J.F. (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med347 (12), 911–20.
Chen, R.T., Pless, R. and Destefano, F. (2001) Epidemiology of autoimmune reactions induced by vaccination. J Autoimmun16 (3), 309–18.
Rose, N.R., and Mackay, I.R. (2006) The Autoimmune Diseases. 4th edition. London: Elsevier Academic Press.
Chen, R.T., et al. (1990) Measles antibody: reevaluation of protective titers. J Infect Dis162 (5), 1036–42.
Schauer, U., et al. (2003) Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults. Clin Diagn Lab Immunol10 (2), 202–7.
Weibel, R.E., et al. (1967) Live attenuated mumps-virus vaccine. 3. Clinical and serologic aspects in a field evaluation. N Engl J Med276 (5), 245–51.
Delrue, I., et al. (2012) Inactivated virus vaccines from chemistry to prophylaxis: merits, risks and challenges. Expert Rev Vaccines11 (6), 695–719.
Dull, P.M., and McIntosh, E.D. (2012) Meningococcal vaccine development – from glycoconjugates against MenACWY to proteins against MenB – potential for broad protection against meningococcal disease. Vaccine30 Suppl 2: B18–25.
Parkman, P.D., and Hopps, H.E. (1988) Viral vaccines and antivirals: current use and future prospects. Annu Rev Public Health 9: 203–21.
Zuckerman, A.J. (1985) Subunit, recombinant and synthetic hepatitis B vaccines. Scand J Gastroenterol Suppl117: 27–38.
Avci, F.Y., et al. (2011) A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design. Nat Med17 (12), 1602–9.
Englund, J.A., et al. (1993) Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis168 (3), 647–56.
Lauring, A.S., Jones, J.O. and Andino, R. (2010) Rationalizing the development of live attenuated virus vaccines. Nat Biotechnol28 (6), 573–9.
Edelman, R. (1980) Vaccine adjuvants. Rev Infect Dis2 (3), 370–83.
Einstein, M.H., et al. (2009) Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years. Hum Vaccin5 (10), 705–19.
Faretra Peysson, L. (2010) Tracing and control of raw materials sourcing for vaccine manufacturers. Biologicals38 (3), 352–3.
Bohlke, K., et al. (2003) Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics112 (4), 815–20.
Hurley, A.M., Tadrous, M., and Miller, E.S. (2010) Thimerosal-containing vaccines and autism: a review of recent epidemiologic studies. J Pediatr Pharmacol Ther15 (3), 173–81.
Offit, P.A. and Jew, R.K. (2003) Addressing parents’ concerns: do vaccines contain harmful preservatives, adjuvants, additives, or residuals? Pediatrics112 (6 Pt 1), 1394–7.
Imafidon, G.I. and Sosulski, F.W. (1990) Nucleic acid nitrogen of animal and plant foods. J Agric Food Chem38 (1), 118–120.
Ghosh, S., et al. (2001) Detection of persistent measles virus infection in Crohn’s disease: current status of experimental work. Gut 48 (6), 748–52.
Khakoo, G.A. and Lack, G. (2000) Recommendations for using MMR vaccine in children allergic to eggs. BMJ320 (7239), 929–32.
Mullins, R.J., Kemp, A. and Gold, M. (2010) Influenza vaccination of the egg-allergic individual. Med J Aust193 (5), 254–5.
DiMiceli, L., et al. (2006) Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS). Vaccine24 (6), 703–7.
Campbell, H., et al., Review of the effect of measles vaccination on the epidemiology of SSPE. Int J Epidemiol, 2007. 36 (6), 1334–48.
Nebbia, G., Peppa, D. and Maini, M.K. (2012) Hepatitis B infection: current concepts and future challenges. QJM105 (2), 109–13.
Pol, S., et al. (2012) Hepatitis C: epidemiology, diagnosis, natural history and therapy. Contrib Nephrol176, 1–9.
McLaughlin-Drubin, M.E., Meyers, J., and Munger, K. 2012 Cancer associated human papillomaviruses. Curr Opin Virol2 (4), 459–66.
Schiffman, M., et al. (2007) Human papillomavirus and cervical cancer. Lancet370 (9590), 890–907.
Kahn, J.A. (2009) HPV vaccination for the prevention of cervical intraepithelial neoplasia. N Engl J Med361 (3), 271–8.
Kimberlin, D.W., and Whitley, R.J. (2007) Varicella-zoster vaccine for the prevention of herpes zoster. N Engl J Med356 (13), 1338–43.
Kim, T.H., Johnstone, J. and Loeb, M. (2011) Vaccine herd effect. Scand J Infect Dis43 (9), 683–9.
Davidkin, I., et al. (2010) MMR vaccination and disease elimination: the Finnish experience. Expert Rev Vaccines9 (9), 1045–53.
Simonsen, L., et al. (2011) Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. MBio2 (1), e00309–10.
Centres for Disease Control and Prevention. (2012) Progress toward interruption of wild poliovirus transmission – worldwide, January 2011 – March 2012. MMWR Morb Mortal Wkly Rep 61 (19), 353–7.
Kahn, C.R. (1989) Perverted priorities. The physician/scientist as spokesman and salesman for biomedical research. Presidential address to the American Society for Clinical Investigation, Washington, DC, 29 April 1989. J Clin Invest84 (3), 723–7.
Beyer, W.E., et al. (1996) Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies. Eur J Clin Microbiol Infect Dis15 (1), 65–70.
Peltola, H., and Heinonen, O.P. (1986) Frequency of true adverse reactions to measles– mumps–rubella vaccine. A double-blind placebo- controlled trial in twins. Lancet1 (8487), 939–42.
Klein N.P., et al. (2010) Measles-mumps- rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics126 (1), e1–8.
Poehling, K.A., et al. (2006) The underrecognized burden of influenza in young children. N Engl J Med355 (1), 31–40.
Parker, S.K., et al. (2004) Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics114 (3), 793–804.
Koppen, S., et al. (2004) No epidemiological evidence for infant vaccinations to cause allergic disease. Vaccine22 (25–26), 3375–85.
Brotherton, J.M., et al. (2008) Anaphylaxis following quadrivalent human papillomavirus vaccination. CMAJ179 (6), 525–33.
Centres for Disease Control and Prevention. (2011) General recommendations on immunization – recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep60 (2), 1–64.
Sheffield, J.S., et al. (2012) Effect of influenza vaccination in the first trimester of pregnancy. Obstet Gynecol120 (3), 532–7.
Tamma, P.D., Steinhoff, M.C. and Omer, S.B. (2010) Influenza infection and vaccination in pregnant women. Expert Rev Respir Med4 (3), 321–8.
Moro, P.L., et al. (2011) Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990–2009. Am J Obstet Gynecol204 (2), 146 e1–7.
Offit, P.A. (2005) The Cutter incident, 50 years later. N Engl J Med352 (14), 1411–2.
White, O.J., et al. (2012) A genomics-based approach to assessment of vaccine safety and immunogenicity in children. Vaccine30 (10), 1865–74.
Mahajan D., Campbell-Lloyd S., Cook J., Menzies R.I. (2011) NSW annual report describing adverse events following immunisation, 2010. N S W Public Health Bull22 (9–10), 196–208.
Lasky, T., et al. (1998) The Guillain–Barre syndrome and the 1992–1993 and 1993–1994 influenza vaccines. N Engl J Med339 (25), 1797–802.
Murphy, T.V., et al. (2001) Intussusception among infants given an oral rotavirus vaccine. N Engl J Med344 (8), 564–72.
Rennels, M.B., et al. (1998) Lack of an apparent association between intussusception and wild or vaccine rotavirus infection. Pediatr Infect Dis J17 (10), 924–5.
Buttery, J.P., et al. (2011) Intussusception following rotavirus vaccine administration: Post-marketing surveillance in the National Immunization Program in Australia. Vaccine29 (16), 3061–3066.
Dey, A., et al. (2012) Changes in hospitalisations for acute gastroenteritis in Australia following the national rotavirus vaccination program. Med J Aust197 (8), 453–7.
World Health Organisation. (2012) Rotavirus vaccines and intussusception. Wkly Epidemiol Rec87 (6), 53–60.
Rappuoli, R., et al. (2011) Vaccines for the twenty-first century society. Nat Rev Immunol11 (12), 865–72.
No authors listed. (2011) World Health Statistics 2011. France: World Health Organisation.
Li, N., et al. (2011) Transcutaneous vaccines: novel advances in technology and delivery for overcoming the barriers. Vaccine29 (37), 6179–90.
van der Maaden, K., Jiskoot, W., and Bouwstra, J. (2012) Microneedle technologies for (trans)dermal drug and vaccine delivery. J Control Release161 (2), 645–55.
Mbow, M.L., et al. (2010) New adjuvants for human vaccines. Curr Opin Immunol22 (3), 411–6.
Rybicki, E.P. (2009) Plant-produced vaccines: promise and reality. Drug Discov Today14 (1–2), 16–24.
Garland, S.M., et al. (2007) Noninferiority of antibody response to human papillomavirus type 16 in subjects vaccinated with monovalent and quadrivalent L1 virus-like particle vaccines. Clin Vaccine Immunol14 (6), 792–5.
Weibel, R.E., et al. (1975) Long-term follow- up for immunity after monovalent or combined live measles, mumps, and rubella virus vaccines. Pediatrics56 (3), 380–7.
Rappuoli, R., and Aderem, A. (2011) A 2020 vision for vaccines against HIV, tuberculosis and malaria. Nature473 (7348), p. 463–9.
de Martel, C., et al., (2012) Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol13 (6), 607–15.
Frazer, I. (2006) God’s gift to women: the human papillomavirus vaccine. Immunity25 (2), 179–84.
Rupnow, M.F., et al. (2009) Cost-effectiveness of a potential prophylactic Helicobacter pylori vaccine in the United States. J Infect Dis200 (8), 1311–7.
Howie, S.E., et al. (2011) Immunity and vaccines against sexually transmitted Chlamydia trachomatis infection. Curr Opin Infect Dis24 (1), 56–61.
Nossal, G.J. (2011) Vaccines of the future. Vaccine29 Suppl 4: D111–5.